Previous data have consistently demonstrated an inhibitory effect of androgens on stress- 
Introduction
The vast distribution of different types of sex steroid hormone receptors within the central nervous system place this class of hormones well beyond the realm of reproductive function (56) . Indeed, testosterone and estrogen exert reliable inhibitory and stimulatory effects, respectively, on activity of the hypothalamic-pituitary-adrenal (HPA) axis, a neuroendocrine system essential for survival (55) . Moreover, individual and gender based differences in normal and abnormal HPA function can be attributed to variations in sex steroid hormone release (46, 51) .
Threats to homeostasis activate the HPA axis by triggering the sequential release of a chain of hormones. This is initiated by the recruitment of neurosecretory neurons in the paraventricular nucleus (PVN) of the hypothalamus that secrete peptide stores from the median eminence, primarily corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) (44) . CRH and AVP synergize on the release of adrenocorticotropin hormone (ACTH) from the anterior pituitary that, in turn, stimulates the release of glucocorticoids from the adrenal gland, cortisol in humans and corticosterone in the rat (1, 3) . A fine balance between glucocorticoid negative feedback inhibition and stress-induced drive to the HPA axis ultimately determines the magnitude of the ACTH response to stress (10, 54) . Testosterone can operate on all of these elements, by exerting inhibitory actions on the cellular and transcriptional activation of PVN motor neurons, ACTH secretagogue synthesis and release, as well as by enhancing glucocorticoid negative feedback efficacy (47, 49) .
There are multiple sites and pathways mediating the central actions of androgens on the HPA axis. Various metabolites of testosterone, including 5α-dihydrotestosterone and its 3β-diol metabolite, are capable of acting locally to inhibit stress-induced levels of PVN Fos mRNA and 4 plasma ACTH and corticosterone (26) . Our connectional studies predict that androgens can also act within a very large assortment of brain regions relaying sensory and limbic information to the PVN region. The medial preoptic nucleus (MPN) stands out in this regard, as we found that it contains the highest concentration of androgen receptor positive efferents to the PVN (56) . In line with this connectional data, testosterone implants into the vicinity of the medial preoptic nucleus reduce the plasma ACTH and corticosterone responses to restraint (50) . Moreover, high testosterone replacement levels in the periphery that normally suppress the magnitude of the HPA stress response fail to do so in rats bearing large electrolytic lesions of the medial preoptic area (50) .
At this point, several uncertainties remain. First, while these electrolytic lesions in the medial preoptic area encompassed the MPN, they were also large enough to have damaged several neighboring subcortical relays to the PVN region. This would include the anterior hypothalamic area; the ventral noradrenergic ascending bundle, which travels through the lateral hypothalamic and lateral preoptic areas; and the posterior medial region of the bed nucleus of the stria terminalis, which markedly inhibits HPA responses to acute stress (8, 9) . Second, while systemic changes in testosterone can operate on CRH and AVP expression and stress-induced levels of Fos within PVN motor neurons (27, 48) , the extent to which a functioning MPN is necessary for these synthetic and cellular stress responses to occur remains to be seen.
In the present study we superimposed two levels of testosterone replacement in the periphery in animals receiving sham or small volume, bilateral injections of ibotenic acid into the MPN. This allowed us to assess how testosterone acts and interacts with the MPN on ACTH secretagogue synthesis, HPA output, and intervening levels of Fos activation within different compartments of the PVN. Of note, the MPN receives and sends input to the medial nucleus of 5 the amygdala (7, 39) , one of many limbic regions expressing androgen receptors (56) and regulating the HPA axis (11) . Testosterone stimulates AVP mRNA and peptide in the medial amygdala (12) , and several lines of evidence continue to relate the inhibitory influence of the gonadal axis on HPA function in males to testosterone dependent increases in extrahypothalamic AVP (17, reviewed in 55) . Based on the potential for the MPN to influence the HPA axis to and through AVP neurons in the medial amygdala, we gauged whether the AVP response to testosterone within this structure also depends on the integrity of the MPN. Our findings indicate that the MPN is integral for testosterone to act on the PVN, as well as its extended circuitries.
Materials and Methods

Animals
Eighty-eight adult male Sprague-Dawley rats (Charles River, St. Constant, Canada) were used, weighing 250 g on arrival (56 days old) and 375 g when sampled (~75 days old). Animals were pair housed under controlled temperature (23±2°C) and lighting conditions (12:12-hour light: dark cycle, lights on at 0600 hours), with food (Labdiet; Rat diet 5012) and water available ad libitum. All experimental protocols were approved by the University of British Columbia Animal Care Committee.
Treatment
To explore how testosterone interacts with the medial preoptic nucleus, body weight matched animals were gonadectomized and randomly assigned to one of the following testosterone replacement-MPN treatment combinations 1) low testosterone-sham, 2) low testosterone-lesion, 3) high testosterone-sham, and 4) high testosterone-lesion, and sampled under basal and/or restraint stress conditions.
Testes were removed via a scrotal incision under ketamine-xylazine-acepromazine anesthesia (25, 5 , and 1 mg/ml, respectively; 1 ml/kg subcutaneously). Each testis was delivered separately through the scrotal incision and removed by severing the vas deferens and spermatic artery, which was ligated to maintain hemostasis. Gonadectomy was completed by closing the scrotal incision with 4-0 non-absorbable suture. Testosterone replacement was performed at the same time, using two subcutaneous Silastic implants (each 35 mm in length, 0.062 mm inner diameter, 1.25 mm outer diameter; Dow Corning, Midland, MI) that were packed with crystalline testosterone (Sigma Aldrich, Oakville, Canada) to a length of 10 mm or 60 mm, for low-and high testosterone replacement, respectively (22) . As shown in the Results, these implants provide plasma testosterone concentrations in the physiological range observed in adult male rats (48, 50) .
Medial preoptic nucleus lesions
Comparing the effects of MPN lesions in gonadal-intact and gonadectomized (GDX) rats with or without testosterone replacement was initially considered. However, this is not the most informative approach for establishing that the MPN is an obligate target for the central actions of testosterone on the HPA axis to occur. As our previous connectional experiments suggest (56) , there are likely several candidate structures in the brain supplying androgen sensitive input to the PVN region, in addition to the MPN. Importantly, GnRH neurons are diffusely distributed throughout a continuum of the medial basal forebrain, including within the region of the MPN (20, 37) . As lesions in the vicinity of the MPN can decrease circulating testosterone levels in 7 animals with testes (23), this approach would not allow us to discern a role for the MPN independently from changes in testosterone release. GDX rats show increases in HPA activity similar to those bearing MPN lesions (48) . Thus, data gleaned from these animals would also lack the specificity for attributing the central effects of testosterone to the MPN. In light of these uncertainties, in the present study we superimposed two levels of testosterone replacement in GDX animals bearing MPN lesions, both to control for testosterone and to specifically address whether the MPN is required for the HPA axis to register differences in testosterone in circulation.
Three days after gonadectomy and testosterone replacement surgeries, rats were anesthetized by injection of sodium pentobarbital (50 mg/kg, ip) and were placed in a Kopf stereotaxic apparatus. To produce discrete, axon sparing lesions (see 23) , rats received bilateral volume injections of ibotenic acid (100 nl, 5 µg/µl in 0.1 M PBS, pH 7.2; Sigma Chemicals, Oakville, Canada) or phosphate buffered saline (Sham lesion; PBS, 0.1 M, pH 7.2) into each MPN sequentially (0.15 mm rostral to bregma, 0.4 mm lateral to the midsagittal sinus, 7.75 mm below the pial surface; bite bar set at 3 mm below the ear bars) using a Hamilton microsyringe (32 gauge blunt needle; Hamilton Company, Reno, USA). The syringe was lowered and kept in position for 5 min prior to injection, which was then delivered at a rate of 10 nl per minute over a ten minute period. To reduce diffusion along the pipette track, the syringe was left in place for an additional 15 min prior to removal. One series of sections through the region of the MPN was counterstained with thionin to examine needle track location and neuron loss. Two additional adjacent series were processed to determine patterns of gliosis and androgen receptor staining.
As described in greater detail in the Results, tissue and blood samples from animals bearing improper or ineffective MPN lesions were removed from the analysis.
Tissue and blood collection
Animals were weighed daily and allowed to recover for 14 days prior to restraint exposure, which involved placing rats into flat bottom Plexiglas restrainers (8. Rats were anesthetized for perfusion after a tail blood sample was taken, either following home cage removal or 60 min following the onset of restraint. Based on our previous time course studies, the 30 min poststress interval is optimal for detecting, within individual animals, both the relative differences in stress-induced indices of HPA function and intervening levels of Fos in PVN attributable to differences in gonadal status (48) . As verified by corneal and pedal pinch reflexes, deep anesthesia was reliably achieved within 1 -2 min of chloral hydrate administration (40% w/v in dH 2 0; 1 ml per 100 g body weight; intraperitoneal). Rats were perfused via the ascending aorta with 0.9% saline, followed by 4% paraformaldehyde (pH 9.5), both at 4°C.
Saline and fixative were delivered over 5 and 20 min, respectively, at a flow rate of 20 ml/min. The testosterone antibody cross-reacts 100% with testosterone and slightly with 5α-dihydrotestosterone (3.40%), 5α-androstane-3β, 17β-diol (2.2%), and 11-oxotestosterone (2%).
The standard curve ED-50 for the testosterone RIA was 1.2 ng/ml, with a detection limit of 0.1 ng/ml. The corticosterone antibody cross-reacts 100% with corticosterone and slightly with desoxycorticosterone (0.34%) and testosterone and cortisol (0.10%) but does not react with the progestins or estrogens (<0.01%). The standard curve ED-50 for the corticosterone RIA was 17 µg/dl, with a detection limit of 0.625 µg/dl. The ACTH antibody cross-reacts 100% with ACTH 1-39 and ACTH , but not with β-endorphin, α-and β-MSH, and α-and β-lipotropin (all <0.8%). The standard curve ED-50 for the ACTH RIA was 82 pg/ml, with a detection limit of 20 pg/ml.
Immunohistochemistry
Lesion placement in the MPN was determined by analyzing patterns of Nissl staining, glial cell infiltration (glial fibrillary acidic protein, GFAP), and androgen receptor staining within adjacent tissue series. Glial cell infiltration was identified using a primary antiserum purified from bovine glial fibrillary acidic protein (AB5804, Lot number 0506002852; Millipore, Billerica, MA; 1:2k).
Androgen receptor (AR) immunoreactive neurons were localized using a primary antiserum Free-floating sections were first rinsed in KPBS buffer to remove cryoprotectant, and then pre-treated with 0.3% hydrogen peroxide for 10 min to quench endogenous peroxidase activity.
This was followed by four rinses in KPBS, and then in sodium borohydride (1% w/v in KPBS) for 5 min to reduce free aldehydes. Sections were then incubated for 48 hours at 4°C in a KPBSTriton (0.3% Triton-X; Sigma-Aldrich, Oakville, Ont.) solution containing 2% normal goat serum and the primary antiserum to detect AR or Fos, as described above. AR and Fos primary antisera were detected using a conventional nickel-intensified, avidin-biotin-immunoperoxidase (Vectastain Elite ABC kit; Vector laboratories, Burlington, CA) procedure (24) . GFAP was detected by using a non-nickel variant of the procedure, as previously described (25) Discrete localization of Fos-ir profiles to the medial dorsal parvocellular (mpd; neurosecretory, anterior pituitary-regulating), and to the dorsal and medial ventral parvocellular (dp and mpv, respectively; nonneurosecretory, autonomic regulating) populations of the PVN was assisted by redirected sampling of an adjacent series of thionin-stained sections. Total cell number estimates of Fos positive cells were generated by counting bilaterally the number of Fospositive cells through each region of interest, averaged by dividing the total number of cell counts by slice number, corrected for double counting errors (19) , and multiplying this product by a factor of five to account for slice frequency (one in five sections).
Characterization of CRH and AVP staining in the median eminence was performed using a dual immunohistochemical labeling technique, including a rabbit polyclonal antibody against CRH (T-4037, Lot number 970177-1; Bachem, Torrance, CA; 1: 2k) and a guinea pig antibody against AVP (T-5048, Lot number 061305; Bachem, Torrance, CA, 1: 25k). Free-floating tissue were prepared as described above, with slight modifications of these procedures to optimize double labeling for CRH-and AVP-ir, including 1) the elimination of hydrogen peroxide pretreatment, 2) using bovine serum albumin as a blocking agent, and 3) incubating tissue sections in primary antisera for 24 hours at 4°C. Primary antisera against CRH and AVP were detected A Leica 40X HCL PL Fluotar objective was used to quantify CRH-and AVPimmunoreactivity localized to the external lamina of the median eminence, the anterior pituitarydirected part of the structure. Optical images from ten regularly spaced (150 µm) sections through the median eminence were acquired and binarized using constant acquisition and threshold parameters. Binarized images were further skeletonized, and the total average density of pixels was recorded as a measure of staining intensity. Parvocellular PVN neurosecretory neurons are acknowledged as the principal source of CRH-ir terminals in the external zone of the median eminence (24, 60) . Determination of AVP staining within terminals specific to this PVN cell population was achieved by redirected sampling of CRH and AVP staining, and by quantifying only those AVP profiles superimposed by CRH positive nerve terminals.
Hybridization histochemistry
A hybridization approach was used under basal conditions to identify how testosterone acts independently or interacts with the MPN on the relative levels of CRH and AVP mRNA in the central and medial nucleus of the amygdala, respectively. CRH and AVP mRNA hybridization histochemistry were carried out using Parceling of the rat brain followed the mapping of Fos immunoreactivity in the PVN, and CRH and AVP mRNA in the amygdala as defined by the morphological features provided by brightness, and final assembly at a resolution of 300 dpi.
Statistics
Data are expressed as the mean ± SEM and were analyzed by using a two-and three-way ANOVA to detect testosterone replacement and MPN lesion effects on Fos under stress conditions, as well as CRH-and AVP-based data under basal conditions. ACTH and corticosterone were analyzed by ANOVA using one repeated measure (time of sample).
Significant ANOVAs were followed using Neuman-Keuls post hoc test. Immuno-and in situ hybridization-histochemical and hormone comparisons were made observer-blind by assigning coded designations to the data sets in advance.
Results
Medial preoptic nucleus lesions
Our pilot studies indicated that bilateral lesions that were centered within, but biased towards the caudal part of the nucleus, were most reliable in terms of inducing elevated plasma ACTH responses to stress. Pilot studies employing a unilateral lesion approach in gonadal intact animals demonstrated a complete loss of androgen receptor staining in the ipsilateral, but not in the contralateral MPN. Furthermore, beyond sparing the amount of damage to fibers of passage (11), the volume and concentration of ibotenic acid used was effective in producing lesions that were histologically distinct and consistently uniform in the animals chosen for analysis.
The extent of the excitotoxin lesions was reliably demarcated by examining local patterns of GFAP induction and loss of androgen receptor staining ( Figs. 1 and 2 ). The caudal part of the MPN is conspicuously composed of magnocellular neurons (38) (39) (40) , and shows a high density of androgen receptor staining that almost completely mirrors its contours. Compared to shams, a lesion was deemed effective in animals showing a loss of androgen receptor staining and magnocellular material, as well as glial infiltration that was centered within the caudal part of the MPN. In general, cellular damage was restricted to the MPN; however, slight damage was occasionally observed within cells occupying the neighboring medial preoptic area and ventral portions of the posterior division of the bed nucleus of the stria terminalis (BST), including the interfascicular nucleus (see Fig. 1 ). While we cannot rule out completely the possible influence of these regions, the interfascicular nucleus has little direct input to the PVN (14) . Furthermore, the principal nucleus, clearly spared in all of the animals examined, appears to be the major subnucleus of the posterior BST responsible for regulating the HPA axis (8, 9).
Rats showing unilateral or non-uniform bilateral lesions were removed from subsequent analysis. Furthermore, animals bearing lesions that were focused beyond the intended caudal part of the MPN or showing damage that extended well into the lateral preoptic and anterior hypothalamic areas were also excluded. Peptide immunoreactivity, mRNA, and stress hormone data were analyzed in only those animals showing proper lesions in the MPN, as independently verified by an observer who was blind to the experimental design. Based on the exclusion criteria described, a final 'n' of 6/group was achieved for each of the four testosterone replacement-MPN treatment combinations.
Body weights
There 
Testosterone replacement and HPA hormones
In gonadectomized, low-and high-testosterone replaced rats, plasma testosterone concentrations were 0.48 ± 0.07 and 2.58 ± 0.08 ng/ml, respectively, validating the reliability of our testosterone replacement regimen. (Fig. 5B) .
Median Eminence CRH-and AVP-ir
Our previous findings indicated that the inhibitory effect of testosterone on stress-induced ACTH release is associated with changes in AVP, but not CRH content in the median eminence (50).
Content measures of median eminence AVP provide, for the most part, an index of magnocellular activity, and both magnocellular and parvocellular neurosecretory neurons contribute to AVP in pituitary portal plasma (3). To provide a more precise index of parvocellular activity, in the current study we used a dual immunohistochemical approach to detect CRH staining in the external zone of the median eminence and to assess the relative levels of AVP contained by these CRH terminals of medial parvocellular origin (Fig. 6) . (Fig. 7B) . In low testosterone rats, AVP staining was comparable between rats bearing sham and MPN lesions (P = 0.15).
Amygdala CRH and AVP mRNA
Densitometric analyses of CRH mRNA through the extent of the central nucleus of the amygdala under basal conditions (Fig. 8 ) indicated a significant effect of testosterone [F(1,20) = 4.6; P < 0.05], but revealed no significant effect of lesion and no significant lesion x testosterone interaction. The effect of testosterone was attributed to an overall inhibitory effect of high testosterone replacement on CRH expression in both sham and MPN lesion groups (Fig. 8D) .
Analysis of AVP mRNA in the anterodorsal part of the medial amygdala ( revealed that the AVP response to high testosterone replacement was significantly higher in shams compared to MPN lesion animals (Fig. 9D ).
Discussion
Our previous experiments showed that lesioning a large extent of the medial preoptic area blocked the inhibitory effects of a single dose of testosterone replacement on HPA function (50).
In the current study we used four treatment groups, encompassing two background levels of testosterone replacement in GDX adult male rats bearing sham and MPN lesions specifically.
Thus, our current design allowed us to make new inroads on how central and peripheral components of the HPA axis responds to differences in circulating testosterone levels and whether the MPN is required for the dose related effect of testosterone to occur.
The data implicate testosterone sensitive pathways from the MPN in mediating both the activational response to stress and biosynthetic capacity of PVN neurosecretory neurons.
Testosterone exerted a dose-related inhibitory effect on restraint-induced levels of Fos within the dorsal medial parvocellular (mpd) part of the PVN as well as ACTH levels in plasma. Within the high testosterone replacement group, rats bearing MPN lesions showed higher levels of stress induced Fos in the mpdPVN and plasma ACTH compared to shams. These findings suggest that testosterone inhibition of HPA effector neurons in the PVN is mediated by androgen receptors located outside the nucleus and that the MPN is required for this mechanism to occur. The extent to which the lesions reflect the removal of testosterone actions that normally occur within or distal to the MPN cannot be ascertained at this point. However, microimplants of the androgen receptor antagonist hydroxyflutamide into the MPN can increase the ACTH response to restraint (57) .
MPN lesioned animals showed significantly higher levels of corticosterone both under basal and stress conditions than did sham-lesioned rats (Fig. 3B) . However, we found no interaction between lesions and testosterone. This was obviously a consequence of the sham group of animals, showing only a slight testosterone dependent decrement in corticosterone levels at 30 min of restraint exposure. This departure between ACTH and corticosterone disagrees with our previous experiments showing negative relations between testosterone and stress-induced ACTH and corticosterone in animals with testes (48, 50) . Our previous GDX + testosterone experiments also show that stress induced levels of ACTH and corticosterone vary strongly and negatively with testosterone (50), in animals replaced over the the entire range of naturally occurring differences in plasma testosterone (~ 0.2 to 7 ng/ml). These findings could explain why we were unable to detect an inhibitory effect on corticosterone using a single, high dose of testosterone replacement. One may still argue that testosterone is of limited significance to the glucocorticoid response, at least in the current study. However, because of our restricted replacement regimen, we can only interpret our data in so far as determining the relative capacity of different central and peripheral components of the HPA axis to respond to a unique level of testosterone.
Our current design, nevertheless, exposed a potential autonomic involvement, perhaps at the level of the PVN, on how testosterone contributes to the net glucocorticoid response. In support of this possibility, sham animals bearing high testosterone replacement showed higher numbers of Fos-ir neurons in the medial parvocellular ventral (mpv) part of the PVN than low testosterone replaced animals under stress conditions (Fig. 5B) . for mediating the actions of testosterone on autonomic function directly, whereas the influence of testosterone on hypophysiotropic function appears to be indirect. We propose that testosterone normally acts on both the autonomic and neuroendocrine arms of the PVN, and that a balance between these systems defines the net glucocorticoid response to stress.
In response to high testosterone replacement, unstressed sham animals showed no change in CRH, but a substantial increase in AVP staining localized to CRH positive terminals in the external lamina of the median eminence (Figs. 6 and 7) . AVP is a weak ACTH secretagogue, but potently enhances the stimulatory effects of CRH on ACTH release (3). Thus, the Testosterone induces GABA activity in the MPN (18, 59) ; and several GABA-rich projections to the PVN, including the MPN, are recruited to express Fos protein and GAD mRNA during stress exposure (6, 34) .
The MPN shows strong bidirectional connections with the medial amygdala (7, 39) , and AVP expression in this region is extremely sensitive to changes in circulating testosterone levels (12) . Several lines of evidence suggest an involvement of extrahypothalamic AVP neurons in mediating the central actions of testosterone on the HPA axis (17, reviewed in 55) . Further, the medial amygdala is critical for the HPA response to stressful stimuli, particularly emotional stressors, such as restraint (11, 16, 21, 28) . Thus, we wondered whether the MPN lesions could influence the AVP response to testosterone within this region of the amygdala (Fig. 9 ). As expected, sham animals displayed an increase in AVP mRNA levels in the medial nucleus of the amygdala in response to high testosterone replacement. This increment in AVP expression, however, was significantly reduced in animals bearing MPN lesions. Assessment of the relative levels of CRH mRNA in the central nucleus of the amygdala revealed no interactions between lesions and testosterone ( Fig. 8) , consistent with the fact that the MPN shows no direct projections to this region of the amygdala (39) . Unlike the medial amygdala, the central nucleus (CeA) appears to be less important for HPA activation in response to restraint (11, 16, 32) .
Thus, our findings argue against a role for the CeA in mediating the central actions of testosterone, at least in response to acute forms of psychological stressors. However, as we observed a main negative effect of testosterone on CRH expression in the CeA, variations in testosterone may differentially prepare the HPA response under more physical or systemic types of challenges (11, 32, 58) .
Virtually all AVP cells in the medial amygdala of the rat are immunoreactive for androgen receptors (12) . While this signifies a local mode of action, our current findings challenge the notion that testosterone regulates AVP neurons in the medial amygdala directly, subject to the influences of the MPN. The medial amygdala, like most limbic regions, has little or no projections to the hypophysiotropic zone of the PVN (8, 21, 31) . The functional influences of the medial amygdala nuclei on the HPA axis, if at all mediated by AVP neurons, may instead involve potential relays in the bed nucleus of the stria terminalis and various hypothalamic structures, including the MPN (8, 21, 55) . The extent to which any of these projections contain AVP, rely on testosterone, and depend on a functioning MPN, remains worthy of pursuit. AVP pathways originating from the medial amygdala have been shown to contribute to a broad, but linked array of behaviors associated with autonomic, emotional, and coping responses to stress (25) . Taken together with our findings, the MPN stands out as an important neural substrate for harmonizing the central actions of testosterone on behavior and neuroendocrine stress responses.
Perspectives and Significance
It is interesting that the functional effects of MPN lesions were discriminated, for the most part, in high-, but not in low-testosterone replaced rats. Circulating levels of testosterone vary as a function of age, sexual experience, social status, time of day, and in response to stress (55) .
Insofar as the MPN is recruited to modulate neuroendocrine, autonomic, and behavioral responses to stress, this may very well depend, therefore, on gonadal status and situation-specific changes in testosterone secretion (17) . It is important to note, at least in the current study, that despite massive changes in central stress pathways and at the pituitary, a single dose of high testosterone did not have a large impact on the net corticosterone response. Previous studies have implicated a critical role for AVP in sustaining corticotroph responsiveness during chronic stress (2) . Taken together, our findings may be relevant to understanding how testosterone determines normal adaptation under repeated stress conditions, in addition to affective disease states associated with changes in adrenal function and gonadal status. Indeed, genuine gender differences in depression and anxiety (33) and the association of depressive illness with hypogonadism in males (35, 36) suggest a potential role for testosterone in the predisposition of mood disorders related to HPA dysfunction. Taken together with the instability of testosterone levels in rodents and humans, and the strength to which the MPN and testosterone interact on the HPA axis, the MPN may be integral to individual differences in HPA function attributed to variations in testosterone release.
Our present findings underscore how testosterone can bridge several independent, yet converging influences on the PVN. The anatomical specificity by which the MPN influences the inhibitory effect of testosterone on HPA axis function still remains unsettled, given the connectivity of the MPN with several other extended circuitries of the PVN, also rich in androgen receptors (39, 56) . This does not indict the utility of our present design, as it provides several tenable bases for revisiting how changes in endogenous testosterone levels are registered within the circuits described, and how this impacts the stress-induced activation of these projections to the PVN. 
